SCHEMBL20009300

SCHEMBL20009300

CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OC(CS(=O)(=O)O)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.50
▸ CES1 P23141 2/20 0.50
▸ TERT O14746 3/20 0.44
▸ PTPN1 P18031 3/20 0.44
▸ PPARG P37231 3/20 0.44
▸ PPARD Q03181 3/20 0.44
▸ PPARA Q07869 3/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ BLM P54132 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ FABP4 P15090 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ GMNN O75496 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20009305 1.00 FAAH (0.50) FAAHCES1TERTPTPN1PPARG
SCHEMBL20009297 1.00 FAAH (0.50) FAAHCES1TERTPTPN1PPARG
SCHEMBL20009304 0.96 ALDH1A1 (0.48) FAAHCES1PPARGPPARDPPARA
SCHEMBL20009286 0.92 LMNA (0.44) FAAHCES1CYP1A2MAPTHSD17B10
SCHEMBL20009294 0.92 LMNA (0.44) FAAHCES1CYP1A2MAPTHSD17B10
SCHEMBL20009284 0.92 LMNA (0.44) FAAHCES1CYP1A2MAPTHSD17B10
SCHEMBL20009271 0.92 LMNA (0.44) FAAHCES1CYP1A2MAPTHSD17B10
SCHEMBL20009272 0.92 LMNA (0.44) FAAHCES1CYP1A2MAPTHSD17B10
SCHEMBL20009296 0.92 LMNA (0.44) FAAHCES1CYP1A2MAPTHSD17B10
SCHEMBL20009274 0.92 LMNA (0.44) FAAHCES1CYP1A2MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10808148-B2 Adhesive composition, bio-electrode, method for manufacturing a bio-electrode, and salt SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-10-20 — — US disclosed
US-20180086948-A1 ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-29 — — US disclosed
US-20180086948-A1 ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10808148-B2 Adhesive composition, bio-electrode, method for manufacturing a bio-electrode, and salt SLC9A1, FN1, EPCAM FAAH 1098/4885CES1 987/4885TERT 1158/4885
US-20180086948-A1 ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT SLC9A1, FN1, EPCAM FAAH 1100/4885CES1 895/4885TERT 1241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback